Physician profile
Jeffrey Friedel
NPI 1699756148
$5,536.07
in general payments reported to CMS, 2019-2025
28 companies · $3,207 in 2025
The $3,207 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $113 · 2021: $116 · 2022: $577 · 2023: $576 · 2024: $740 · 2025: $3,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,959 · Travel and Lodging: $1,563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,959.16 |
| Travel and Lodging | $1,563.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,916.57 | 2024-2025 | Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $661.93 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $394.07 | 2019-2025 | Farxiga, Lokelma, Wainua |
| Abbott Laboratories | $332.03 | 2020-2025 | Cardiomems, Confirm Rx, Jot Dx |
| Edwards Lifesciences Corporation | $232.04 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novartis Pharmaceuticals Corporation | $197.42 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $191.96 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $171.67 | 2022-2025 | Camzyos, Eliquis |
| Stryker Corporation | $167.76 | 2025 | Venacore Thrombectomy Catheter |
| Pfizer INC. | $166.52 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.99 | 2022-2025 | Jardiance |
| Recor Medical INC | $156.76 | 2025 | Paradise Ultrasound Renal Denervation System |
| Teleflex LLC | $103.29 | 2022-2023 | Supercross |
| Merck Sharp & Dohme LLC | $93.55 | 2022-2025 | Verquvo |
| Amgen INC. | $93.19 | 2021-2023 | Repatha |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bracco Diagnostics INC. | $87.40 | 2024-2025 | |
| Abiomed | $62.25 | 2025 | |
| Inari Medical, INC. | $55.68 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $44.07 | 2025 | Linq II |
| Kestra Medical Technology Services, INC. | $42.95 | 2022 | |
| Inspire Medical Systems, INC. | $38.94 | 2024-2025 | Inspire |
| Boston Scientific Corporation | $35.19 | 2025 | Wolverine Coronary Cutting Balloon |
| Cleerly, INC. | $30.67 | 2023 | Cleerly Labs |
| Portola Pharmaceuticals, LLC | $24.66 | 2019 | |
| Shockwave Medical, INC | $22.89 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $17.66 | 2025 | Wegovy |
| Regeneron Healthcare Solutions, INC. | $16.21 | 2025 | Evkeeza |
| Chiesi USA, INC. | $13.75 | 2025 | Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Friedel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.